This document outlines a presentation on goiter awareness. It aims to empower laypeople to have a basic understanding of thyroid goiter for their health management. The presentation covers what goiter is, its different types and causes, how to recognize it, diagnostic tests, treatment options, and post-treatment management. The overall goal is to provide reliable information to give patients power and control over decisions regarding the medical management of thyroid goiter.
Surgical management of pancreatic pseudocyst..by dr chris alumonaCHRIS ALUMONA
The document summarizes the surgical management of pancreatic pseudocysts. It presents a case study of a 40-year-old male with recurrent abdominal pain. Imaging revealed a large fluid collection in the pancreas consistent with a pseudocyst. The document then reviews the relevant anatomy, etiology, classification, pathophysiology, clinical evaluation, differential diagnosis, investigation and treatment options for pancreatic pseudocysts. Key treatment approaches discussed include conservative management, percutaneous drainage, endoscopic drainage, and surgical drainage via cystogastrostomy or cystojejunostomy.
This document discusses hydatid cyst of the liver, which is caused by the parasite Echinococcus granulosus transmitted by dogs. After being swallowed, the parasite's eggs penetrate the stomach and travel to the liver through blood vessels. In the liver, they grow and form hydatid cysts with multiple protective layers. Hydatid cysts can be asymptomatic or cause abdominal pain. Diagnosis involves imaging and blood tests. Treatment options include surgery to remove cysts, medication with albendazole, or watchful waiting for inactive cysts.
Intestinal obstruction in children can have several causes including duodenal hematoma from blunt trauma or bleeding disorders, duplication cysts appearing as cystic masses on imaging, and Meckel's diverticulum which can cause bleeding or intussusception. Appendicitis presents with abdominal pain localized to the right lower quadrant. Henoch-Schonlein purpura causes small bowel vasculitis and presents with abdominal pain and rash. Imaging can identify thickened bowel loops, free fluid, and inflamed lymph nodes in appendicitis or bowel wall thickening in other causes of obstruction. Intussusception is a common cause in infants appearing as a soft tissue mass on x-ray or concentric rings on
Congenital anamalies of biliary system aryajaRamesh Bhat
This document discusses various congenital anomalies of the biliary system. It describes abnormalities that can occur in the gallbladder, hepatic ducts, cystic duct, arteries, and other structures. Some key points include:
- The gallbladder may be absent, duplicated, located on the left side, or intrahepatic.
- Accessory hepatic ducts occur in around 15% of cases.
- Variations can occur in the origins of the cystic and hepatic arteries.
- The cystic duct can drain into various locations and have other anomalies.
- Choledochal cysts are cystic dilations that can affect different parts of the biliary tree.
- Congenital biliary at
Treatment of fistula in ano focuses on controlling sepsis, defining the anatomy of the fistula, and excluding other diseases. For simple fistulas, options include fibrin glue, fistulotomy, and seton placement. Complex fistulas may require fistulotomy with seton, LIFT procedure, advancement flaps, or fistula plug. Fistulotomy has a high success rate but risks incontinence. Seton placement helps drain complex fistulas but can cause long term incontinence. The LIFT procedure is sphincter sparing for complex transsphincteric fistulas with a primary healing rate of 62% and no incontinence. Success rates and risks vary depending on the procedure and complexity of the
This Presentation gives general overview of how patient with Choledochal Cyst presents and what workup should be done and how such patients should be managed
Cystic diseases of the liver can be diagnosed using imaging such as ultrasound, CT, or MRI scans. Simple hepatic cysts appear as thin-walled lesions with homogenous interiors, while polycystic liver disease involves multiple cysts throughout the liver. Hydatid cysts may contain daughter cysts. Liver abscesses appear cystic but can usually be diagnosed clinically. Cystadenomas and cystadenocarcinomas often have thick, irregular walls with heterogeneous interiors and septations. Imaging helps characterize cystic lesions and guide treatment.
Surgical management of pancreatic pseudocyst..by dr chris alumonaCHRIS ALUMONA
The document summarizes the surgical management of pancreatic pseudocysts. It presents a case study of a 40-year-old male with recurrent abdominal pain. Imaging revealed a large fluid collection in the pancreas consistent with a pseudocyst. The document then reviews the relevant anatomy, etiology, classification, pathophysiology, clinical evaluation, differential diagnosis, investigation and treatment options for pancreatic pseudocysts. Key treatment approaches discussed include conservative management, percutaneous drainage, endoscopic drainage, and surgical drainage via cystogastrostomy or cystojejunostomy.
This document discusses hydatid cyst of the liver, which is caused by the parasite Echinococcus granulosus transmitted by dogs. After being swallowed, the parasite's eggs penetrate the stomach and travel to the liver through blood vessels. In the liver, they grow and form hydatid cysts with multiple protective layers. Hydatid cysts can be asymptomatic or cause abdominal pain. Diagnosis involves imaging and blood tests. Treatment options include surgery to remove cysts, medication with albendazole, or watchful waiting for inactive cysts.
Intestinal obstruction in children can have several causes including duodenal hematoma from blunt trauma or bleeding disorders, duplication cysts appearing as cystic masses on imaging, and Meckel's diverticulum which can cause bleeding or intussusception. Appendicitis presents with abdominal pain localized to the right lower quadrant. Henoch-Schonlein purpura causes small bowel vasculitis and presents with abdominal pain and rash. Imaging can identify thickened bowel loops, free fluid, and inflamed lymph nodes in appendicitis or bowel wall thickening in other causes of obstruction. Intussusception is a common cause in infants appearing as a soft tissue mass on x-ray or concentric rings on
Congenital anamalies of biliary system aryajaRamesh Bhat
This document discusses various congenital anomalies of the biliary system. It describes abnormalities that can occur in the gallbladder, hepatic ducts, cystic duct, arteries, and other structures. Some key points include:
- The gallbladder may be absent, duplicated, located on the left side, or intrahepatic.
- Accessory hepatic ducts occur in around 15% of cases.
- Variations can occur in the origins of the cystic and hepatic arteries.
- The cystic duct can drain into various locations and have other anomalies.
- Choledochal cysts are cystic dilations that can affect different parts of the biliary tree.
- Congenital biliary at
Treatment of fistula in ano focuses on controlling sepsis, defining the anatomy of the fistula, and excluding other diseases. For simple fistulas, options include fibrin glue, fistulotomy, and seton placement. Complex fistulas may require fistulotomy with seton, LIFT procedure, advancement flaps, or fistula plug. Fistulotomy has a high success rate but risks incontinence. Seton placement helps drain complex fistulas but can cause long term incontinence. The LIFT procedure is sphincter sparing for complex transsphincteric fistulas with a primary healing rate of 62% and no incontinence. Success rates and risks vary depending on the procedure and complexity of the
This Presentation gives general overview of how patient with Choledochal Cyst presents and what workup should be done and how such patients should be managed
Cystic diseases of the liver can be diagnosed using imaging such as ultrasound, CT, or MRI scans. Simple hepatic cysts appear as thin-walled lesions with homogenous interiors, while polycystic liver disease involves multiple cysts throughout the liver. Hydatid cysts may contain daughter cysts. Liver abscesses appear cystic but can usually be diagnosed clinically. Cystadenomas and cystadenocarcinomas often have thick, irregular walls with heterogeneous interiors and septations. Imaging helps characterize cystic lesions and guide treatment.
Presentation2.pptx, radiological imaging of gastric lesions.Abdellah Nazeer
This document provides an overview of gastric pathology that can be imaged radiologically. It begins with the normal gross anatomy and appearances of the stomach. It then discusses various non-neoplastic anomalies, infections, ulcers, polyps, hypertrophic gastropathies, and other non-neoplastic lesions that can affect the stomach. The document proceeds to discuss dysplasia, neuroendocrine tumors, carcinomas, lymphomas, stromal and other tumors, as well as features related to staging and evaluating treatment effects of gastric conditions. Throughout it provides examples of various pathologies and the radiological features used to image them.
Most liver cysts are benign and noncancerous, forming fluid-filled sacs. While many cause no symptoms, some inherited disorders can lead to clusters of liver cysts requiring treatment. Liver cysts are usually diagnosed through ultrasound, CT scan, or MRI imaging and most often require no treatment. However, large cysts or those causing pain or other issues may be drained, have their walls removed, or be treated through embolization or surgery.
1) An intestinal fistula is an abnormal connection between two epithelial surfaces, most commonly the intestine and skin (enterocutaneous). The ileum is the most common site of origin.
2) Fistulas can be classified anatomically by their connections or physiologically by their output. Enterocutaneous fistulas usually result from complications of intestinal surgery.
3) Management of intestinal fistulas involves stabilization of the patient through fluid resuscitation, nutritional support, and controlling sepsis before considering definitive surgical repair once the patient's condition has improved.
This document discusses gall bladder cancer. It notes that gall bladder cancer is rare and traditionally incurable, with late presentation and disseminated disease at diagnosis leading to a dismal prognosis. Complete surgical resection is the main treatment option, with a 5-year survival rate of only 5%. Risk factors include chronic cholelithiasis and inflammation. Staging and surgical management depend on the extent of disease, with more advanced stages requiring liver resection or extended surgery.
This document provides an overview of gall bladder carcinoma. It discusses the epidemiology, etiology, pathology, histology, presentation, workup, treatment and follow up of gall bladder cancer. Gall bladder cancer is relatively uncommon but the 5th most common gastrointestinal malignancy worldwide. Chronic inflammation from gallstones is the main risk factor. Imaging studies like ultrasound, CT and MRI are used to diagnose and stage the cancer. Surgery is the main treatment but the outcome is often poor due to late diagnosis and aggressive nature of the disease.
The gallbladder is a pear-shaped organ that stores and concentrates bile produced by the liver. It can be affected by various congenital anomalies and gallstones. Gallstones are usually cholesterol stones but some may be pigment stones related to hemolytic conditions. Cholecystitis, or inflammation of the gallbladder, can be acute or chronic and is usually caused by gallstones. Gallbladder cancer is rare but associated with conditions like gallstones and chronic infection. Cancers can also occur in the bile ducts and ampulla of Vater.
This document provides guidelines for the treatment of gastric cancer from the National Comprehensive Cancer Network (NCCN). It was updated in January 2022 and includes:
1) Revisions to the recommended workup, including universal testing for microsatellite instability by PCR, next-generation sequencing, or mismatch repair immunohistochemistry for all newly diagnosed patients.
2) A recommendation for perioperative chemotherapy as the preferred primary treatment for medically fit patients with locoregional cT2 or higher gastric cancer.
3) Revisions to the principles of pathologic biomarker testing, including consideration of next-generation sequencing if sufficient tissue is available after initial testing.
This document discusses various tumours of the peritoneum. It begins by providing background on the anatomy and histology of the peritoneum. It then describes the classification and characteristics of different tumour types that can arise in the peritoneum, including malignant mesothelioma, serous carcinomas, leiomyomatosis, and desmoplastic small round cell tumour. Diagnostic criteria and immunohistochemistry profiles are outlined to help distinguish between tumour types. Secondary metastases to the peritoneum from other organ sites are also briefly mentioned.
The document discusses cholelithiasis (gallstones) and acute cholecystitis (inflammation of the gallbladder). It covers the prevalence and types of gallstones, risk factors, potential complications, clinical presentation, diagnosis and treatment options. For acute cholecystitis, conservative treatment with antibiotics and fluids is usually attempted first to resolve the inflammation before delayed cholecystectomy once symptoms subside.
Choledocholithiasis refers to stones in the common bile duct. Stones can be primary, forming directly in the bile duct, or secondary, originating from the gallbladder. Clinical features include biliary colic, jaundice, fever, and complications like cholangitis. Investigations include ultrasound, MRCP, CT, and ERCP. Treatment involves ERCP with sphincterotomy and stone extraction, or open exploration during cholecystectomy. For retained stones, techniques include T-tube flushing or reoperation with transduodenal sphincteroplasty or choledochojejunostomy.
This document provides information about various benign breast conditions including cysts, fibroadenomas, hyperplasia, intraductal papillomas, sclerosing adenosis, radial scars, galactocele, lipoma, LCIS, and phyllodes tumor. It defines each condition, describes symptoms, risk factors, diagnosis, and treatment. Case studies are presented to demonstrate clinical presentations and diagnostic workups for each condition. The goal is to educate about non-cancerous breast disorders and their management.
Urinary Bladder Tumor
The document discusses urinary bladder tumors. It covers the incidence, risk factors, signs and symptoms, types and classification, staging, and radiological findings of bladder tumors. Bladder cancer is the second most common urological malignancy and is more common in men than women. Major risk factors include smoking and occupational exposure to carcinogens. Common presenting symptoms are painless visible blood in the urine and recurrent urinary tract infections. Types include urothelial carcinoma (90% of cases), squamous cell carcinoma, and adenocarcinoma. Staging uses the TNM system. Radiological exams like ultrasound, CT, and MRI can identify bladder tumors and their extent.
This document provides an overview of gastric carcinoma, including:
- Causes of epigastric lumps that may indicate gastric carcinoma
- Risk factors like H. pylori infection, diet, smoking, and genetic factors
- Staging classifications including TNM, Lauren-Jarvi, and Borrmann systems
- Treatment approaches like endoscopic or surgical resection depending on stage, with lymph node dissection and reconstruction techniques described
- Adjuvant therapies including chemotherapy and radiation to improve survival
- 5-year survival rates are improved with neoadjuvant chemotherapy and adjuvant chemoradiation compared to surgery alone.
This document discusses diseases of the gallbladder and bile ducts. It covers topics like cholecystitis (inflammation of the gallbladder), choledocholithiasis (gallstones in the bile ducts), and cholangitis (infection and inflammation of the bile ducts). Signs, symptoms, diagnostic tests, and treatments are described for various conditions. Risk factors for gallstone formation include obesity, pregnancy, and hereditary conditions. Complications can include perforation or fistula formation. Conditions are typically diagnosed using ultrasound, CT, or ERCP and treated with antibiotics, stone dissolution therapies, or cholecystectomy.
The document provides information on imaging of intestinal obstruction. It discusses the types, causes, clinical presentations and imaging features of small bowel obstruction and large bowel obstruction. Key points include that small bowel obstruction is more common and can be caused by adhesions, hernias and tumors. Imaging findings on x-ray include dilated bowel loops and air-fluid levels. Closed loop obstruction has a characteristic "U-shaped" bowel configuration. Large bowel obstruction is usually due to cancer in adults. Common causes of neonatal bowel obstruction discussed include duodenal atresia, jejunal atresia, ileal atresia, meconium ileus and Hirschsprung's disease.
This document contains questions and explanations from a surgery exam question bank website. It includes 5 multiple choice questions about the anatomy of the liver ducts, risk factors for colon cancer, atypical symptoms of appendicitis, common cysts of the spleen, and location of gastric ulcers. For each question, the correct answer is provided along with a short explanation of the topic and a link to additional questions on the website.
Anal fissure and haemorrhoids are common painful conditions caused by constipation or hard stools. Anal fissures are tears in the lining of the anal canal that cause sharp pain during bowel movements. Haemorrhoids are swollen veins in the anal canal that can cause bleeding. Treatment depends on severity but includes dietary changes, topical ointments, injection therapy, surgery. Sphincterotomy or fissurectomy may be needed for chronic anal fissures that do not heal with conservative treatment.
The document discusses a patient empowerment program (PEP) talk on goiter awareness. It provides definitions of goiter and discusses the different types of goiter classified by clinical presentation and disease categories. It describes the common causes of goiter and how to recognize different types. It also outlines the usual diagnostic tests, treatments, and post-treatment management for various goiter types. The talk aims to provide laypeople with a basic understanding of thyroid goiter for their health management.
ROJoson PEP Talk: GOITER Management Part 2 - Fundamentals and GeneralitiesReynaldo Joson
ROJoson PEP Talk: GOITER Management Part 2 - Fundamentals and Generalities
Contents:
Clinical Diagnosis of Goiters
Paraclinical Diagnostic Procedures for Goiters
Presentation2.pptx, radiological imaging of gastric lesions.Abdellah Nazeer
This document provides an overview of gastric pathology that can be imaged radiologically. It begins with the normal gross anatomy and appearances of the stomach. It then discusses various non-neoplastic anomalies, infections, ulcers, polyps, hypertrophic gastropathies, and other non-neoplastic lesions that can affect the stomach. The document proceeds to discuss dysplasia, neuroendocrine tumors, carcinomas, lymphomas, stromal and other tumors, as well as features related to staging and evaluating treatment effects of gastric conditions. Throughout it provides examples of various pathologies and the radiological features used to image them.
Most liver cysts are benign and noncancerous, forming fluid-filled sacs. While many cause no symptoms, some inherited disorders can lead to clusters of liver cysts requiring treatment. Liver cysts are usually diagnosed through ultrasound, CT scan, or MRI imaging and most often require no treatment. However, large cysts or those causing pain or other issues may be drained, have their walls removed, or be treated through embolization or surgery.
1) An intestinal fistula is an abnormal connection between two epithelial surfaces, most commonly the intestine and skin (enterocutaneous). The ileum is the most common site of origin.
2) Fistulas can be classified anatomically by their connections or physiologically by their output. Enterocutaneous fistulas usually result from complications of intestinal surgery.
3) Management of intestinal fistulas involves stabilization of the patient through fluid resuscitation, nutritional support, and controlling sepsis before considering definitive surgical repair once the patient's condition has improved.
This document discusses gall bladder cancer. It notes that gall bladder cancer is rare and traditionally incurable, with late presentation and disseminated disease at diagnosis leading to a dismal prognosis. Complete surgical resection is the main treatment option, with a 5-year survival rate of only 5%. Risk factors include chronic cholelithiasis and inflammation. Staging and surgical management depend on the extent of disease, with more advanced stages requiring liver resection or extended surgery.
This document provides an overview of gall bladder carcinoma. It discusses the epidemiology, etiology, pathology, histology, presentation, workup, treatment and follow up of gall bladder cancer. Gall bladder cancer is relatively uncommon but the 5th most common gastrointestinal malignancy worldwide. Chronic inflammation from gallstones is the main risk factor. Imaging studies like ultrasound, CT and MRI are used to diagnose and stage the cancer. Surgery is the main treatment but the outcome is often poor due to late diagnosis and aggressive nature of the disease.
The gallbladder is a pear-shaped organ that stores and concentrates bile produced by the liver. It can be affected by various congenital anomalies and gallstones. Gallstones are usually cholesterol stones but some may be pigment stones related to hemolytic conditions. Cholecystitis, or inflammation of the gallbladder, can be acute or chronic and is usually caused by gallstones. Gallbladder cancer is rare but associated with conditions like gallstones and chronic infection. Cancers can also occur in the bile ducts and ampulla of Vater.
This document provides guidelines for the treatment of gastric cancer from the National Comprehensive Cancer Network (NCCN). It was updated in January 2022 and includes:
1) Revisions to the recommended workup, including universal testing for microsatellite instability by PCR, next-generation sequencing, or mismatch repair immunohistochemistry for all newly diagnosed patients.
2) A recommendation for perioperative chemotherapy as the preferred primary treatment for medically fit patients with locoregional cT2 or higher gastric cancer.
3) Revisions to the principles of pathologic biomarker testing, including consideration of next-generation sequencing if sufficient tissue is available after initial testing.
This document discusses various tumours of the peritoneum. It begins by providing background on the anatomy and histology of the peritoneum. It then describes the classification and characteristics of different tumour types that can arise in the peritoneum, including malignant mesothelioma, serous carcinomas, leiomyomatosis, and desmoplastic small round cell tumour. Diagnostic criteria and immunohistochemistry profiles are outlined to help distinguish between tumour types. Secondary metastases to the peritoneum from other organ sites are also briefly mentioned.
The document discusses cholelithiasis (gallstones) and acute cholecystitis (inflammation of the gallbladder). It covers the prevalence and types of gallstones, risk factors, potential complications, clinical presentation, diagnosis and treatment options. For acute cholecystitis, conservative treatment with antibiotics and fluids is usually attempted first to resolve the inflammation before delayed cholecystectomy once symptoms subside.
Choledocholithiasis refers to stones in the common bile duct. Stones can be primary, forming directly in the bile duct, or secondary, originating from the gallbladder. Clinical features include biliary colic, jaundice, fever, and complications like cholangitis. Investigations include ultrasound, MRCP, CT, and ERCP. Treatment involves ERCP with sphincterotomy and stone extraction, or open exploration during cholecystectomy. For retained stones, techniques include T-tube flushing or reoperation with transduodenal sphincteroplasty or choledochojejunostomy.
This document provides information about various benign breast conditions including cysts, fibroadenomas, hyperplasia, intraductal papillomas, sclerosing adenosis, radial scars, galactocele, lipoma, LCIS, and phyllodes tumor. It defines each condition, describes symptoms, risk factors, diagnosis, and treatment. Case studies are presented to demonstrate clinical presentations and diagnostic workups for each condition. The goal is to educate about non-cancerous breast disorders and their management.
Urinary Bladder Tumor
The document discusses urinary bladder tumors. It covers the incidence, risk factors, signs and symptoms, types and classification, staging, and radiological findings of bladder tumors. Bladder cancer is the second most common urological malignancy and is more common in men than women. Major risk factors include smoking and occupational exposure to carcinogens. Common presenting symptoms are painless visible blood in the urine and recurrent urinary tract infections. Types include urothelial carcinoma (90% of cases), squamous cell carcinoma, and adenocarcinoma. Staging uses the TNM system. Radiological exams like ultrasound, CT, and MRI can identify bladder tumors and their extent.
This document provides an overview of gastric carcinoma, including:
- Causes of epigastric lumps that may indicate gastric carcinoma
- Risk factors like H. pylori infection, diet, smoking, and genetic factors
- Staging classifications including TNM, Lauren-Jarvi, and Borrmann systems
- Treatment approaches like endoscopic or surgical resection depending on stage, with lymph node dissection and reconstruction techniques described
- Adjuvant therapies including chemotherapy and radiation to improve survival
- 5-year survival rates are improved with neoadjuvant chemotherapy and adjuvant chemoradiation compared to surgery alone.
This document discusses diseases of the gallbladder and bile ducts. It covers topics like cholecystitis (inflammation of the gallbladder), choledocholithiasis (gallstones in the bile ducts), and cholangitis (infection and inflammation of the bile ducts). Signs, symptoms, diagnostic tests, and treatments are described for various conditions. Risk factors for gallstone formation include obesity, pregnancy, and hereditary conditions. Complications can include perforation or fistula formation. Conditions are typically diagnosed using ultrasound, CT, or ERCP and treated with antibiotics, stone dissolution therapies, or cholecystectomy.
The document provides information on imaging of intestinal obstruction. It discusses the types, causes, clinical presentations and imaging features of small bowel obstruction and large bowel obstruction. Key points include that small bowel obstruction is more common and can be caused by adhesions, hernias and tumors. Imaging findings on x-ray include dilated bowel loops and air-fluid levels. Closed loop obstruction has a characteristic "U-shaped" bowel configuration. Large bowel obstruction is usually due to cancer in adults. Common causes of neonatal bowel obstruction discussed include duodenal atresia, jejunal atresia, ileal atresia, meconium ileus and Hirschsprung's disease.
This document contains questions and explanations from a surgery exam question bank website. It includes 5 multiple choice questions about the anatomy of the liver ducts, risk factors for colon cancer, atypical symptoms of appendicitis, common cysts of the spleen, and location of gastric ulcers. For each question, the correct answer is provided along with a short explanation of the topic and a link to additional questions on the website.
Anal fissure and haemorrhoids are common painful conditions caused by constipation or hard stools. Anal fissures are tears in the lining of the anal canal that cause sharp pain during bowel movements. Haemorrhoids are swollen veins in the anal canal that can cause bleeding. Treatment depends on severity but includes dietary changes, topical ointments, injection therapy, surgery. Sphincterotomy or fissurectomy may be needed for chronic anal fissures that do not heal with conservative treatment.
The document discusses a patient empowerment program (PEP) talk on goiter awareness. It provides definitions of goiter and discusses the different types of goiter classified by clinical presentation and disease categories. It describes the common causes of goiter and how to recognize different types. It also outlines the usual diagnostic tests, treatments, and post-treatment management for various goiter types. The talk aims to provide laypeople with a basic understanding of thyroid goiter for their health management.
ROJoson PEP Talk: GOITER Management Part 2 - Fundamentals and GeneralitiesReynaldo Joson
ROJoson PEP Talk: GOITER Management Part 2 - Fundamentals and Generalities
Contents:
Clinical Diagnosis of Goiters
Paraclinical Diagnostic Procedures for Goiters
ROJoson PEP Talk: GOITER Management - Part 1 - Fundamentals and GeneralitiesReynaldo Joson
ROJoson PEP Talk: GOITER Management - Part 1 - Fundamentals and Generalities
Contents:
What is a goiter?
What are the different types of goiter?
What are the causes of goiter?
How common are the goiters?
ROJoson PEP Talk: THYROID - GOITER - BOSYO AWARENESSReynaldo Joson
This document outlines the details of a Patient Empowerment Program (PEP) Talk on thyroid, goiter, and bosyo (Filipino term for goiter) awareness. The objectives are to provide laypeople with a basic understanding of these topics in managing their health. The PEP Talk will be held via Zoom and include discussions on the thyroid gland and its functions, different types of goiters and their causes, methods for recognizing goiters, diagnostic tests and treatments, and advice for layperson management. Participants are encouraged to ask questions, provide feedback, and take an online evaluation test to receive a certificate.
Basic introduction to Health screening in Malaysia.
Health screening refers to the process of testing or examining people who do not have symptoms of a particular disease or condition to identify if they are at risk of developing it. This type of screening can help detect diseases or conditions at an early stage, before symptoms develop, allowing for earlier treatment and a better chance of a positive outcome. Health screening can also identify risk factors that individuals may have for developing certain diseases, which can help guide preventive measures and lifestyle modifications to reduce the risk of developing the disease.
Health screening can take many different forms, depending on the disease or condition being screened for and the population being targeted.
Some common types of health screenings include:
Cancer screenings: Screening tests for cancer can help detect tumors or other abnormalities in the body before symptoms develop. Examples of cancer screenings include mammograms for breast cancer, colonoscopies for colon cancer, and Pap tests for cervical cancer.
Cardiovascular disease screenings: These screenings help identify risk factors for heart disease and stroke, such as high blood pressure, high cholesterol, and diabetes. Tests might include blood pressure checks, cholesterol tests, and glucose tests.
Infectious disease screenings: Testing for infectious diseases like HIV, hepatitis, and sexually transmitted infections can help identify people who are infected and in need of treatment, as well as prevent the spread of these diseases to others.
Genetic screenings: Some health screenings are designed to identify genetic mutations that increase the risk of certain conditions, such as breast cancer or cystic fibrosis.
The benefits of health screening can be significant, as detecting diseases or risk factors early can lead to better outcomes and quality of life for individuals. However, health screening also has some potential downsides, including the possibility of false-positive or false-negative results, anxiety or distress related to the screening process, and overdiagnosis and overtreatment of conditions that may never have caused harm. To maximize the benefits of health screening while minimizing the potential risks, it is important to carefully consider which screening tests are appropriate for each individual based on their age, sex, medical history, and other risk factors. Health screening should also be part of a broader approach to preventive care that includes healthy lifestyle choices, regular check-ups with a healthcare provider, and appropriate immunizations.
In conclusion, health screening is an important tool for identifying diseases and risk factors early, but it is important to approach it with caution and careful consideration of individual needs and risk factors. With proper use, health screening can be an effective tool for promoting health and preventing disease.
ROJoson PEP Talk: When to say you have a GOITER?Reynaldo Joson
This document is a transcript of a presentation on when to say you have a goiter. The presentation emphasizes the importance of monthly neck self-examination and consulting a thyroid specialist if abnormalities are found. It advises that if neck self-examination reveals an enlarged thyroid, nodules, enlarged lymph nodes, or symptoms of hyperthyroidism or hypothyroidism, one should say they have a goiter. It also recommends validating any self-discovered findings with a thyroid specialist, who will examine the neck, make a diagnosis, and recommend next steps such as monitoring, tests, medications or surgery. The overall message is for laypeople to understand when they may have a goiter through self-examination and when to consult an
ROJoson PEP Talk: When to say you have a GOITER?Reynaldo Joson
The document discusses when a person should say they have a goiter. It begins by explaining what a goiter is - an abnormality in the thyroid gland that can be either functional (too much or too little hormone secretion) or structural (enlarged gland or nodules). It emphasizes the importance of monthly neck self-examinations to check for abnormalities. If a lump, enlargement or nodule is found, or symptoms of hyperthyroidism or hypothyroidism are present, a person should say they have a goiter. The next step is consulting a thyroid specialist, who will examine the neck, make a diagnosis, and recommend next steps, which may include observation or additional tests and treatment.
ROJoson PEP Talk: JAUNDICE - Overview - May 07, 2022Reynaldo Joson
This document provides an overview of a presentation on the fundamentals and generalities of the medical management of jaundice. The presentation covers: defining jaundice and the different types; common causes; how clinical diagnosis is made through history, exam and diagnostic testing; and basic treatment modalities depending on the specific cause. The goal is to empower laypeople with a basic understanding of jaundice to help them take a more active role in managing their health.
- The patient is a 49-year-old male presenting with 2 months of abdominal pain, loss of appetite, early satiety, and weight loss. On physical examination, a tender abdominal mass was palpated measuring approximately 20x13cm.
- CT scan showed an intra-abdominal mass arising from the greater curvature of the stomach, measuring 11.61cm x 19.44cm with central necrosis.
- A provisional diagnosis of mesenteric tumor (GIST) was made, with differential diagnoses of adenocarcinoma of the small intestine and lymphoma of the small intestine. Further workup and management are pending.
This document provides an overview of geriatrics and aging. It defines geriatrics as the care of aged people and notes it is a subspecialty of internal medicine focused on prevention and treatment of age-related disabilities. Key points include:
- Geriatrics aims to address common problems in old age like immobility, instability, intellectual impairment, incontinence, and multiple medical issues.
- Comprehensive Geriatric Assessment is a multidisciplinary approach to evaluate older patients' medical, psychological and functional status to maximize health and quality of life.
- Research seeks to understand aging processes to develop interventions that may slow or stop aging through approaches like modifying gene expression, repairing telomeres, or
The document discusses a presentation on goiter myths and tips for patient empowerment. It aims to help laypeople understand common issues regarding goiter. The presentation covers 5 myths: the concept of goiter, foods related to goiter, internal vs external goiter descriptions, TSH interpretation, and low-dose suppressive therapy. Tips are provided to clarify the myths and empower patients with reliable health information. The summary emphasizes gaining knowledge to make informed health decisions.
This document provides information about bariatric/metabolic surgery and what patients should know. It discusses why weight loss is important for improving health and quality of life. The goals of surgery are lower body weight, improved quality of life, reduced morbidity, and cost effectiveness. Different types of operations are described, including gastric band, gastric bypass, and sleeve gastrectomy. Expected weight loss is 25-30% of excess weight long term. Surgery resolves many obesity-related health conditions and complications are rare. Close follow up is required after surgery. Surgery is now being considered as a treatment for type 2 diabetes and other metabolic conditions even in patients with mild obesity.
ROJoson PEP Talk: Thyroid Cancer Management - Part 1 - Fundamentals and Gener...Reynaldo Joson
The document discusses fundamentals and generalities in the medical management of thyroid cancer. It covers screening for thyroid cancer through risk assessment, physical examination, and diagnostic procedures if suspicious symptoms are present. Clinical diagnosis of thyroid cancer involves evaluating symptoms and signs through pattern recognition and prevalence. Alert symptoms for thyroid cancer include lumps on the central neck, side neck, or neck with persistent hoarseness of voice.
ROJoson PEP Talk: ABDOMINAL OBSTRUCTION - OVERVIEWReynaldo Joson
START THINKING OF POSSIBLE BILIARY TRACT OBSTRUCTION.
CUE FOR OBSTRUCTION: PALPABLE MASS IN THE LIVER!
LOCATION OF THE MASS!
RIGHT UPPER QUADRANT – LIVER, GALLBLADDER, PANCREAS
Similar to ROJoson PEP Talk: GOITER AWARENESS (20)
ROJoson PEP Talk: High Blood Pressure (Hypertension) ManagementReynaldo Joson
The document provides information about a zoom session on April 13, 2024 from 1400H to 1500H on High Blood Pressure (Hypertension) Management. The objective is for laypeople to have an essential understanding of managing hypertension as part of their health management. The session will include a presentation, group pictures, an online test for a certificate, and feedback in the chat box. [/SUMMARY]
ROJoson PEP Talk: Does Biopsy Make Cancer Spread?Reynaldo Joson
This document contains information from a presentation on whether biopsies can cause cancer to spread. It defines a biopsy as a procedure that removes a sample of tissues, cells, or fluid from the body to examine for diagnosis. Different types of biopsies are described, including those that remove samples versus whole masses. Benefits of biopsies include obtaining a definite diagnosis to guide treatment planning. The document discusses the fear that biopsies may cause cancer seeding or spread, and defines cancer seeding as cancer cells spreading along the needle track during a biopsy.
ROJoson PEP Talk: Developing a Breast Self-Exam Habit through a Motivating AwardReynaldo Joson
This document outlines a Zoom presentation on developing a breast self-exam habit through motivating awards. It provides logistical details for the event, including the date, time, and instructions for participants. The presentation aims to teach laypeople how to perform breast self-exams and develop the habit through an awards program. It will cover what breast self-exams are, their importance, and how to properly conduct one. The speaker will advocate for their breast self-exam awards initiative to motivate more women to regularly perform self-exams.
ROJoson PEP Talk: CAN ONE SKIP RADIOACTIVE IODINE THERAPY IN THYROID CANCER T...Reynaldo Joson
The document discusses radioactive iodine therapy (RAIT) for thyroid cancer treatment. RAIT involves using radioactive iodine-131, which is taken orally and concentrates in thyroid tissue to destroy cancer cells. It is effective for papillary and follicular thyroid cancers. RAIT is used for remnant ablation after surgery, adjuvant therapy to prevent recurrence, and treatment of known disease. While commonly recommended in the past, the use of RAIT has evolved to focus on patients at higher risk, as not all thyroid cancers require aggressive treatment like RAIT. The document questions whether RAIT can be skipped in some patients.
ROJoson PEP Talk: Can one skip RADIOACTIVE IODINE THERAPY in Thyroid Cancer T...Reynaldo Joson
The document discusses radioactive iodine therapy (RAIT) for thyroid cancer treatment. RAIT involves using radioactive iodine-131, which is taken orally and concentrates in thyroid tissue to destroy cancer cells. It is effective for papillary and follicular thyroid cancers. RAIT is used for remnant ablation after surgery, adjuvant therapy to prevent recurrence, and treatment of known disease. While commonly recommended in the past, the use of RAIT has evolved to focus on patients at higher risk of recurrence rather than applying it routinely, as many thyroid cancers have excellent outcomes with surgery alone. The document questions whether RAIT can be skipped in some patients with a very low risk.
ROJoson PEP Talk: DOES EVERYONE HAVE CANCER CELLS IN THEIR BODY?Reynaldo Joson
The document discusses whether everyone has cancer cells in their body. It explains that while our bodies are constantly producing new cells, not all of these cells are destined to become cancerous. A typical healthy cell goes through cycles of growth, division and death, while a cancer cell does not follow this normal cycle and keeps reproducing abnormally. Not everyone inherently has cancer cells in their body from the beginning - it is possible for initially normal cells to eventually develop into cancer cells due to certain risk factors.
ROJoson PEP Talk: Can one skip CHEMOTHERAPY in BREAST CANCER TREATMENT?Reynaldo Joson
Chemotherapy is a systemic cancer treatment that uses powerful drugs to destroy fast-growing cancer cells. It works by keeping cancer cells from growing and dividing. Chemotherapy can be given alone or with other treatments depending on the cancer type and stage. Factors like a person's age, health, and the cancer details help determine the chemotherapy plan and drugs. Chemotherapy aims to cure cancer, shrink tumors before other treatments, destroy remaining cancer cells after treatment, or slow cancer progression and relieve symptoms.
ROJoson PEP Talk: Do all patients need painkillers after an operation?Reynaldo Joson
This document provides information from a Patient Empowerment Program (PEP) Talk on the use of painkillers after an operation. The PEP Talk aims to give laypeople an essential understanding of painkiller use after surgery in managing their health. It discusses that not all patients need painkillers after an operation, as some procedures do not involve cutting or cause pain. It also outlines factors that govern physician prescription and patient intake of postoperative painkillers.
ROJoson PEP Talk: Do all patients need painkillers after an operation?Reynaldo Joson
The document discusses whether all patients need painkillers after an operation. Not all patients require painkillers, as some operations do not involve cuts or incisions and are thus not painful. Whether painkillers are prescribed depends on factors like the usual pain from the procedure and the patient's pain threshold. Patients should monitor their pain levels at home and follow physician advice on appropriate painkiller use.
ROJoson PEP Talk: Cancer Surveillance after Definitive TreatmentReynaldo Joson
This document summarizes a zoom presentation on cancer surveillance after definitive treatment. The presentation aims to empower laypeople by providing an essential understanding of cancer surveillance as part of health management. It discusses what cancer surveillance after treatment is, how it is done through monitoring symptoms, physical exams, and tests, and why it is important lifelong. It also covers different approaches to surveillance and emphasizes educating patients on symptoms of recurrence to watch out for based on their cancer type.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
1. Empowerment
objective - for
laypeople to have a
basic understanding
of THYROID GOITER
in their health
management.
GOITER
AWARENESS
January 21, 2023
1400H - 1500H
Via Zoom
2. Empowerment
objective - for
laypeople to have a
basic understanding
of THYROID GOITER
in their health
management.
GOITER
AWARENESS
ROJoson PEP Talk
I have a Patient
Empowerment
Program in which I
like to empower the
lay people or
patients to take
control in the
management of
their health.
3. I started the PEP Talk
on May 15, 2021.
There are 3 courses in
the PEP Talk.
I completed the Core
Course on October 9,
2021.
4. From October 23,
2021 onwards, I have
been tackling Health
Disorder and Health
Issue Courses. This
may take 3 years or
longer.
5. Empowerment
objective - for
laypeople to have a
basic understanding
of THYROID GOITER
in their health
management.
GOITER
AWARENESS
My PEP TALK today is
entitled:
GOITER
AWARENESS
This is my
contribution to
the PH DOH
Goiter Awareness
Week (4th week of
January).
6. Contents
• What is a goiter?
• What are the different types of goiter?
• What are the causes of goiter?
• How to recognize goiter and its different
types?
• What paraclinical diagnostic tests are usually
done for goiter?
• What are the usual treatment for the different
types of goiter?
• What are the post-treatment management for
goiter?
GOITER
AWARENESS
8. GOITER
AWARENESS
What is a goiter?
Loosely speaking, goiter refers to
something wrong with the thyroid gland, a
butterfly-shaped organ located in the base
and central part of the neck.
Goiter is defined as any disorder in the
thyroid gland.
9. GOITER
AWARENESS
What is a goiter?
The thyroid gland is a vital organ (vital organ –
one that is needed to survive) that regulates
metabolism, growth and development of the
human body. The thyroid gland makes, releases,
and controls thyroid hormones that control
metabolism. Metabolism is a process where the
food taken into body is transformed into energy.
This energy is used throughout the entire body to
keep many of the body's systems working
correctly.
12. GOITER
AWARENESS
What are the different types of goiter?
Goiter can be classified into several categories:
By clinical presentation (diffuse or nodular
goiter; euthyroidism, hyperthyroidism,
hypothyroidism)
By general categories of diseases (malignant vs
non-malignant disorders; hyperthyroidism vs
hypothyroidism)
By names of specific disease
13. GOITER
AWARENESS
What are the different types of goiter?
Clinical Classification of Goiter:
• Diffuse toxic goiter (with diffuse enlargement
with hyperthyroidism)
• Diffuse non-toxic goiter (with diffuse
enlargement without hyperthyroidism – may
be euthyroidism or hypothyroidism)
• Nodular toxic goiter (with nodule/s with
hyperthyroidism)
• Nodular non-toxic goiter (with nodule/s
without hyperthyroidism may be euthyroidism
or hypothyroidism)
14. GOITER
AWARENESS
What are the different types of goiter?
Definition of diffuse enlargement – the major
lobes of the thyroid glands such as the right and
left lobes are almost symmetrically enlarged or
increase in size and without nodule/s
15. GOITER
AWARENESS
What are the different types of goiter?
Definition of nodules – presence of nodule /
nodules or lump/lumps / dominant mass/es
17. GOITER
AWARENESS
What are the different types of goiter?
Diffuse enlargement – Hyperthyroidism, hypothyroidism or
euthyroidism (depending on the associated symptoms and
signs)
Nodule formation – Malignant vs non-malignant disorders
18. GOITER
AWARENESS
What are the different types of goiter?
Common diseases that I usually diagnose which
can be recognized clinically and relatively
common in the community:
• Hyperthyroidism (Graves’ Disease)
• Hyperthyroidism (unspecified)
• Hypothyroidism
• Acute thyroiditis
• Chronic thyroiditis
19. GOITER
AWARENESS
What are the different types of goiter?
Common diseases that I usually diagnose which
can be recognized clinically and relatively
common in the community:
Malignant nodules or thyroid cancers:
• Papillary carcinoma
• Follicular carcinoma
• Anaplastic carcinoma
• Medullary carcinoma
20. GOITER
AWARENESS
What are the different types of goiter?
Common diseases that I usually diagnose which
can be recognized clinically and relatively
common in the community:
Non-malignant nodules or conditions:
• Colloid cyst
• Colloid adenomatous nodule
• Multiple colloid adenomatous goiter
• *Diffuse colloid adenomatous goiter
22. GOITER
AWARENESS
What are the causes of goiter?
In general, risk factors include:
• Genetic predisposition
• Environmental influence – like lack of
iodine intake; excessive exposure to
radiation to the neck; stress
NOTE: A lot of goiters have NO definite
known cause.
23. GOITER
AWARENESS
What are the causes of goiter?
More specific causes for specific diseases:
• Iodine deficiency goiter – lack of iodine intake
• Colloid adenomatous goiter – physiologic and
degenerative condition
• Cancer – genetic mutation with genetic
predisposition and radiation exposure
• Chronic thyroiditis – autoimmune disease
• Acute thyroiditis – infection
• Hyperthyroidism – autoimmune disease
• Hypothyroidism – iodine deficiency, physiologic
24. GOITER
AWARENESS
What are the causes of goiter?
Except for iodine deficiency goiter due to lack of
iodine intake which can be prevented, for the
other diseases, one, nobody can predict when
one is going to have a thyroid disease and two,
the causes are realistically difficult to identify and
to control.
Healthy lifestyle with adequate iodine intake is
the best bet against thyroid diseases. However,
there is a percentage that one cannot prevent a
thyroid disease from occurring even with a
healthy lifestyle.
26. GOITER
AWARENESS
How to recognize goiter and its different
types?
• Lump/s on the front, base and central
part of the neck which moves up and
down with swallowing
• Lump/s on the side of the neck
• Palpitation
• Sudden weight loss
• Persistent fatigue
28. GOITER
AWARENESS
How to recognize goiter and its different
types?
• Palpitation
• Sudden weight loss
Cues or alert-signals for
HYPERTHYROIDISM
29. GOITER
AWARENESS
How to recognize goiter and its different
types?
• Lump/s on the front, base and central
part of the neck which moves up and
down with swallowing
• Lump/s on the side of the neck
Cues or alert-signals for tumors which
could be benign or malignant (need more
sign-cues)
31. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Common instrumental and laboratory diagnostic
procedures that can be used after the clinical
diagnosis of goiter:
• Thyroid function tests – FT3, FT4, TSH
• Imaging procedures – ultrasound, thyroid scan,
CT Scan, MRI, PET Scan
• Needle aspiration ± biopsy
32. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Thyroid function tests – FT3, FT4, TSH
to check level of thyroid hormones in the blood –
euthyroid; hyperthyroid; hypothyroid.
Indications:
• when not sure whether a patient has
hyperthyroid or hypothyroid
• when needed to have a baseline and follow-up
values to monitor subsequent medical
treatment
33. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Thyroid function tests
Interpretations:
• Normal FT4 and normal TSH – euthyroidism
• Elevated FT4 and below normal TSH –
hyperthyroidism
• Below normal FT4 and elevated TSH -
hypothyroidism
34. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Imaging procedures – ultrasound, thyroid scan, CT
Scan, MRI, PET Scan
Indication:
When needed to evaluate the structure
(ultrasound, CT Scan, MRI) and at times, function
of the thyroid gland (thyroid scan and PET Scan)
Choose the most cost-effective ones.
35. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Imaging procedures – ultrasound, thyroid scan, CT
Scan, MRI, PET Scan
Indication:
Ultrasound, CT scan, MRI can be used to evaluate
the structure - size of the thyroid gland and
whether a nodule present is benign or malignant.
Choose the most cost-effective ones.
36. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Imaging procedures – ultrasound, thyroid scan, CT
Scan, MRI, PET Scan
Indication:
Thyroid scan using a radioactive isotope is used
primarily to determine whether there is nodule
that is hyperfunctioning or not.
Choose the most cost-effective ones.
37. GOITER
AWARENESS
What paraclinical diagnostic tests are
usually done for goiter?
Needle aspiration ± biopsy
Indications:
• When needed to determine whether a nodule
is solid or cystic (if cystic, needle aspiration
may be therapeutic in outcome)
• When needed to get a sample of solid nodule
for biopsy (whether benign or malignant - at
times the specific disease can be revealed)
39. GOITER
AWARENESS
What are the usual treatment for the
different types of goiter?
• Watchful waiting
• Medications
• Operations
• RAI therapy
• Chemotherapy
40. GOITER
AWARENESS
Treatment for Non-Cancer Goiters
Goiters with functional disorders
• Hyperthyroidism
• Hypothyroidism
Goiters with non-functional disorders and benign
conditions
• Colloid adenomatous goiters
Goals of treatment
Curative vs control
• Some don’t recur
after treatment!
• Some recur!
Only time will tell!
NO GUARANTEE FOR
CURE!
May need lifetime
maintenance meds!
41. GOITER
AWARENESS
Treatment for HYPOTHYROIDISM Goals of treatment
Curative vs control
• Some don’t recur
after treatment!
• Some recur!
Only time will tell!
NO GUARANTEE FOR
CURE!
May need lifetime
maintenance meds!
Medical therapy (NO OPERATION as this will
aggravate the hypothyroidism)
Replacement therapy – thyroid hormones, usually
levothyroxine – usually lifetime!
42. GOITER
AWARENESS
Treatment for HYPERTHYROIDISM Goals of treatment
Curative vs control
• Some don’t recur
after treatment!
• Some recur!
Only time will tell!
NO GUARANTEE FOR
CURE!
May need lifetime
maintenance meds!
3 options for goiters that are small to moderate in
size:
• Medical therapy with anti-thyroid drugs
• Operative therapy
• Radioactive iodine therapy
For huge-size goiters, operative therapy is
recommended!
43. GOITER
AWARENESS
Treatment for COLLOID ADENOMATOUS
GOITERS
4 categories:
• Diffuse colloid adenomatous goiter
• Colloid cyst
• Solitary colloid adenomatous goiter or nodule
• Multiple colloid adenomatous goiter
Options:
• Monitor without
meds
• Meds (levothyroxine)
• Operation
• Operation is
recommended for
huge-size goiter.
• Small to moderate
ones, no operation
(monitor without
meds or with meds)
44. GOITER
AWARENESS
Treatment for Non-Cancer Goiters
Goiters with functional disorders
• Hyperthyroidism
• Hypothyroidism
Goiters with non-functional disorders and benign
conditions
• Colloid adenomatous goiters
Goals of treatment
Curative vs control
• Some don’t recur
after treatment!
• Some recur!
Only time will tell!
NO GUARANTEE FOR
CURE!
May need lifetime
maintenance meds!
SURVEILLANCE OR
MONITORING NEEDED – LIFE
TIME!
45. GOITER
AWARENESS
Treatment for Thyroid Cancers
4 common types of thyroid cancers
• Papillary carcinoma
• Follicular carcinoma
• Medullary carcinoma
• Anaplastic carcinoma
46. GOITER
AWARENESS
Treatment for Thyroid Cancers
The usual goals of thyroid cancer treatment
include
• eradicating known tumors / cancers entirely,
preventing the recurrence or spread of the
primary cancer, and
• relieving symptoms if all reasonable curative
approaches have been exhausted.
Curative goal
Palliative goal
47. GOITER
AWARENESS
Treatment for Thyroid Cancers
4 common types of thyroid cancers
• Papillary carcinoma
• Follicular carcinoma
• Medullary carcinoma
• Anaplastic carcinoma
For curative goal:
• Primary treatment modality: OPERATION
• May be followed by radioactive iodine
therapy
• May be followed by medical suppressive
therapy using levothyroxine
For palliative goal:
• Chemotherapy
• Radiation therapy
50. GOITER
AWARENESS
What are the post-treatment
management?
After treatment for any type of goiter,
• Non-cancer goiters
• Cancer goiters (particularly)
there must be surveillance or follow-up or check-
up – usually lifetime – for recurrence.
Early detection of recurrence early treatment
better outcome!
51. GOITER
AWARENESS
What are the post-treatment
management?
Patients may be taking maintenance meds for
control of disease – may be lifetime!
Patients are advised to have a healthy lifestyle to
promote health restoration and maintenance.
Except for ANAPLASTIC THYROID CA (fortunately
rare) and advanced cancers, the rest can still have
a long life after treatment.
52. Contents
• What is a goiter?
• What are the different types of goiter?
• What are the causes of goiter?
• How to recognize goiter and its different
types?
• What paraclinical diagnostic tests are usually
done for goiter?
• What are the usual treatment for the different
types of goiter?
• What are the post-treatment management for
goiter?
GOITER
AWARENESS
Summary
Take Away
53. GOITER
AWARENESS
Take Away in
relation to
Patient
Empowerment
Be always in touch with reliable medical
information on THYROID GOITER.
Knowledge is power; it gives power.
Use the 4Ks of Patient Empowerment:
Kaalaman, Kakayanan, Karapatan and
Kapangyarihan
to gain greater control over decisions in
medical management of THYROID GOITER.
54. Empowerment
objective - for
laypeople to have a
basic understanding
of THYROID GOITER
in their health
management.
GOITER
AWARENESS
My PEP TALK today is
entitled:
GOITER
AWARENESS
This is my
contribution to
the PH DOH
Goiter Awareness
Week (3rd week of
January).